QED is proud to announce that it has been shortlisted in the category of “Best CRO” in the 5th Annual Scrip awards. This competition, organized by Scrip World Pharmaceutical News, a major provider of news and analysis for the global biopharmaceutical industry, promotes new standards of excellence and celebrates achievements that reflect the innovating nature of the industry. QED has been nominated alongside several leading global CROs by an illustrious panel of pharmaceutical industry experts.
Scrip’s Best CRO Award is given in recognition of the key role CROs play in drug development. QED are confident that their success in building trust and solid working relationships, and its development as a highly innovative and flexible organisation, make it a crucial CRO partner for the pharmaceutical industry.